Browsing Tag
cANK-101
1 post
Ankyra Therapeutics’ cANK-101 delivers promising preliminary data in canine melanoma trial
Ankyra Therapeutics, a biotech innovator, unveiled groundbreaking preliminary results from their exploratory Phase 1 canine clinical trial today.…